Prevalence and Risk Factors of Women Mental Health Disorders

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04792671
Collaborator
(none)
200
30

Study Details

Study Description

Brief Summary

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. On the other hand, Depressive disorder in women mainly occurs during the first year after childbirth. It takes many forms according to the onset, severity, and duration of the symptoms including; Postpartum blues (PPB), Postpartum depression (PPD), and Postpartum psychosis (PPP). Lack of access to mental health services during the perinatal period is a significant public health concern that may worse outcome.

So, we aimed to study prevalence of women mental health in Assiut governorate and evaluate possible risk factor for it

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sociodemographic variables
  • Behavioral: Family affluence scale (FAS)
  • Behavioral: Edinburgh postnatal depression scale (EPDS)
  • Behavioral: Symptom Checklist 90 "SCL 90":

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Prevalence and Risk Factors of Women Mental Health Disorders in Assiut Governorate
Anticipated Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Perinatal group

females who are pregnancy

Behavioral: Sociodemographic variables
age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.

Behavioral: Family affluence scale (FAS)
a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.

Behavioral: Edinburgh postnatal depression scale (EPDS)
s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed

Behavioral: Symptom Checklist 90 "SCL 90":
is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

postpartum group

female who get delivery(from day 1 up to 1 year)

Behavioral: Sociodemographic variables
age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.

Behavioral: Family affluence scale (FAS)
a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.

Behavioral: Edinburgh postnatal depression scale (EPDS)
s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed

Behavioral: Symptom Checklist 90 "SCL 90":
is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

Outcome Measures

Primary Outcome Measures

  1. measure the prevalence of DSM 5 psychiatric disorders in perinatal and postnatal [through study completion, an average of 1 year]

  2. measure of risk factor of DSM 5 psychiatric disorders in perinatal and postnatal [through study completion, an average of 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age 18 years -50 years.

  • No previous history of psychiatric, neurological or medical disease

Exclusion Criteria:
  • intelligence equation less than 80

  • have history of psychiatric, neurological or medical disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gellan Karamalllah Ramadan Ahmed, lecturer, resarcher OF Neurology and Psychiatry department, Assiut University
ClinicalTrials.gov Identifier:
NCT04792671
Other Study ID Numbers:
  • women mental health disorders
First Posted:
Mar 11, 2021
Last Update Posted:
Mar 11, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gellan Karamalllah Ramadan Ahmed, lecturer, resarcher OF Neurology and Psychiatry department, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 11, 2021